InsidersTradesSigma
Follow the 셀루메드 share price and the full insider trade history of the company, a listed issuer based in South Korea. Shares trade on KR KR, under the supervision of DART (FSS). Operating in the Health Care sector, 셀루메드 has logged 1 public disclosures. Market capitalisation: €83.9bn. The latest transaction was reported on 19 March 2026 (Sale). Among the most active insiders: 인스코비. Every trade is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
셀루메드 operates in the healthcare and pharmaceutical sector, listed on the XKRX market. The company focuses on developing innovative solutions for the medical field.